img

Global Platinum Anti-tumor Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Platinum Anti-tumor Drugs Market Insights, Forecast to 2034

Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
Market Analysis and InsightsGlobal Platinum Anti-tumor Drugs Market
Global Platinum Anti-tumor Drugs market is expected to reach to US$ 1581 million in 2024, with a positive growth of %, compared with US$ 1527 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Platinum Anti-tumor Drugs industry is evaluated to reach US$ 1876.8 million in 2029. The CAGR will be 2.9% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Platinum Anti-tumor Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Platinum Anti-tumor Drugs market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Viatris
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
Segment by Type
Cisplatin
Oxaliplatin
Carboplatin
Other

Segment by Application


Colorectal Cancer
Ovarian Cancer
Lung Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Platinum Anti-tumor Drugs introduction, etc. Platinum Anti-tumor Drugs Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Platinum Anti-tumor Drugs
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Platinum Anti-tumor Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cisplatin
1.2.3 Oxaliplatin
1.2.4 Carboplatin
1.2.5 Other
1.3 Market by Application
1.3.1 Global Platinum Anti-tumor Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Colorectal Cancer
1.3.3 Ovarian Cancer
1.3.4 Lung Cancer
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Platinum Anti-tumor Drugs Market Perspective (2018-2029)
2.2 Global Platinum Anti-tumor Drugs Growth Trends by Region
2.2.1 Platinum Anti-tumor Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Platinum Anti-tumor Drugs Historic Market Size by Region (2018-2024)
2.2.3 Platinum Anti-tumor Drugs Forecasted Market Size by Region (2024-2029)
2.3 Platinum Anti-tumor Drugs Market Dynamics
2.3.1 Platinum Anti-tumor Drugs Industry Trends
2.3.2 Platinum Anti-tumor Drugs Market Drivers
2.3.3 Platinum Anti-tumor Drugs Market Challenges
2.3.4 Platinum Anti-tumor Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Platinum Anti-tumor Drugs by Players
3.1.1 Global Platinum Anti-tumor Drugs Revenue by Players (2018-2024)
3.1.2 Global Platinum Anti-tumor Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Platinum Anti-tumor Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Platinum Anti-tumor Drugs, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Platinum Anti-tumor Drugs Market Concentration Ratio
3.4.1 Global Platinum Anti-tumor Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Platinum Anti-tumor Drugs Revenue in 2022
3.5 Global Key Players of Platinum Anti-tumor Drugs Head office and Area Served
3.6 Global Key Players of Platinum Anti-tumor Drugs, Product and Application
3.7 Global Key Players of Platinum Anti-tumor Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Platinum Anti-tumor Drugs Breakdown Data by Type
4.1 Global Platinum Anti-tumor Drugs Historic Market Size by Type (2018-2024)
4.2 Global Platinum Anti-tumor Drugs Forecasted Market Size by Type (2024-2029)
5 Platinum Anti-tumor Drugs Breakdown Data by Application
5.1 Global Platinum Anti-tumor Drugs Historic Market Size by Application (2018-2024)
5.2 Global Platinum Anti-tumor Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Platinum Anti-tumor Drugs Market Size (2018-2029)
6.2 North America Platinum Anti-tumor Drugs Market Size by Type
6.2.1 North America Platinum Anti-tumor Drugs Market Size by Type (2018-2024)
6.2.2 North America Platinum Anti-tumor Drugs Market Size by Type (2024-2029)
6.2.3 North America Platinum Anti-tumor Drugs Market Share by Type (2018-2029)
6.3 North America Platinum Anti-tumor Drugs Market Size by Application
6.3.1 North America Platinum Anti-tumor Drugs Market Size by Application (2018-2024)
6.3.2 North America Platinum Anti-tumor Drugs Market Size by Application (2024-2029)
6.3.3 North America Platinum Anti-tumor Drugs Market Share by Application (2018-2029)
6.4 North America Platinum Anti-tumor Drugs Market Size by Country
6.4.1 North America Platinum Anti-tumor Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Platinum Anti-tumor Drugs Market Size by Country (2018-2024)
6.4.3 North America Platinum Anti-tumor Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Platinum Anti-tumor Drugs Market Size (2018-2029)
7.2 Europe Platinum Anti-tumor Drugs Market Size by Type
7.2.1 Europe Platinum Anti-tumor Drugs Market Size by Type (2018-2024)
7.2.2 Europe Platinum Anti-tumor Drugs Market Size by Type (2024-2029)
7.2.3 Europe Platinum Anti-tumor Drugs Market Share by Type (2018-2029)
7.3 Europe Platinum Anti-tumor Drugs Market Size by Application
7.3.1 Europe Platinum Anti-tumor Drugs Market Size by Application (2018-2024)
7.3.2 Europe Platinum Anti-tumor Drugs Market Size by Application (2024-2029)
7.3.3 Europe Platinum Anti-tumor Drugs Market Share by Application (2018-2029)
7.4 Europe Platinum Anti-tumor Drugs Market Size by Country
7.4.1 Europe Platinum Anti-tumor Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Platinum Anti-tumor Drugs Market Size by Country (2018-2024)
7.4.3 Europe Platinum Anti-tumor Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Platinum Anti-tumor Drugs Market Size (2018-2029)
8.2 China Platinum Anti-tumor Drugs Market Size by Type
8.2.1 China Platinum Anti-tumor Drugs Market Size by Type (2018-2024)
8.2.2 China Platinum Anti-tumor Drugs Market Size by Type (2024-2029)
8.2.3 China Platinum Anti-tumor Drugs Market Share by Type (2018-2029)
8.3 China Platinum Anti-tumor Drugs Market Size by Application
8.3.1 China Platinum Anti-tumor Drugs Market Size by Application (2018-2024)
8.3.2 China Platinum Anti-tumor Drugs Market Size by Application (2024-2029)
8.3.3 China Platinum Anti-tumor Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Platinum Anti-tumor Drugs Market Size (2018-2029)
9.2 Asia Platinum Anti-tumor Drugs Market Size by Type
9.2.1 Asia Platinum Anti-tumor Drugs Market Size by Type (2018-2024)
9.2.2 Asia Platinum Anti-tumor Drugs Market Size by Type (2024-2029)
9.2.3 Asia Platinum Anti-tumor Drugs Market Share by Type (2018-2029)
9.3 Asia Platinum Anti-tumor Drugs Market Size by Application
9.3.1 Asia Platinum Anti-tumor Drugs Market Size by Application (2018-2024)
9.3.2 Asia Platinum Anti-tumor Drugs Market Size by Application (2024-2029)
9.3.3 Asia Platinum Anti-tumor Drugs Market Share by Application (2018-2029)
9.4 Asia Platinum Anti-tumor Drugs Market Size by Region
9.4.1 Asia Platinum Anti-tumor Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Platinum Anti-tumor Drugs Market Size by Region (2018-2024)
9.4.3 Asia Platinum Anti-tumor Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Platinum Anti-tumor Drugs Introduction
11.1.4 Sanofi Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.1.5 Sanofi Recent Developments
11.2 Hengrui Medicine
11.2.1 Hengrui Medicine Company Details
11.2.2 Hengrui Medicine Business Overview
11.2.3 Hengrui Medicine Platinum Anti-tumor Drugs Introduction
11.2.4 Hengrui Medicine Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.2.5 Hengrui Medicine Recent Developments
11.3 ASK Pharma
11.3.1 ASK Pharma Company Details
11.3.2 ASK Pharma Business Overview
11.3.3 ASK Pharma Platinum Anti-tumor Drugs Introduction
11.3.4 ASK Pharma Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.3.5 ASK Pharma Recent Developments
11.4 Yi Bai Pharmaceutical
11.4.1 Yi Bai Pharmaceutical Company Details
11.4.2 Yi Bai Pharmaceutical Business Overview
11.4.3 Yi Bai Pharmaceutical Platinum Anti-tumor Drugs Introduction
11.4.4 Yi Bai Pharmaceutical Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.4.5 Yi Bai Pharmaceutical Recent Developments
11.5 Qilu Pharmaceutical
11.5.1 Qilu Pharmaceutical Company Details
11.5.2 Qilu Pharmaceutical Business Overview
11.5.3 Qilu Pharmaceutical Platinum Anti-tumor Drugs Introduction
11.5.4 Qilu Pharmaceutical Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.5.5 Qilu Pharmaceutical Recent Developments
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Platinum Anti-tumor Drugs Introduction
11.6.4 Teva Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.6.5 Teva Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Platinum Anti-tumor Drugs Introduction
11.7.4 Pfizer Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.7.5 Pfizer Recent Developments
11.8 Dr Reddy's Laboratories
11.8.1 Dr Reddy's Laboratories Company Details
11.8.2 Dr Reddy's Laboratories Business Overview
11.8.3 Dr Reddy's Laboratories Platinum Anti-tumor Drugs Introduction
11.8.4 Dr Reddy's Laboratories Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.8.5 Dr Reddy's Laboratories Recent Developments
11.9 Viatris
11.9.1 Viatris Company Details
11.9.2 Viatris Business Overview
11.9.3 Viatris Platinum Anti-tumor Drugs Introduction
11.9.4 Viatris Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.9.5 Viatris Recent Developments
11.10 Sun Pharma
11.10.1 Sun Pharma Company Details
11.10.2 Sun Pharma Business Overview
11.10.3 Sun Pharma Platinum Anti-tumor Drugs Introduction
11.10.4 Sun Pharma Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.10.5 Sun Pharma Recent Developments
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Platinum Anti-tumor Drugs Introduction
11.11.4 Novartis Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.11.5 Novartis Recent Developments
11.12 Debiopharm
11.12.1 Debiopharm Company Details
11.12.2 Debiopharm Business Overview
11.12.3 Debiopharm Platinum Anti-tumor Drugs Introduction
11.12.4 Debiopharm Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.12.5 Debiopharm Recent Developments
11.13 Accord Healthcare
11.13.1 Accord Healthcare Company Details
11.13.2 Accord Healthcare Business Overview
11.13.3 Accord Healthcare Platinum Anti-tumor Drugs Introduction
11.13.4 Accord Healthcare Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.13.5 Accord Healthcare Recent Developments
11.14 SK Chemicals
11.14.1 SK Chemicals Company Details
11.14.2 SK Chemicals Business Overview
11.14.3 SK Chemicals Platinum Anti-tumor Drugs Introduction
11.14.4 SK Chemicals Revenue in Platinum Anti-tumor Drugs Business (2018-2024)
11.14.5 SK Chemicals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Platinum Anti-tumor Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Cisplatin
Table 3. Key Players of Oxaliplatin
Table 4. Key Players of Carboplatin
Table 5. Key Players of Other
Table 6. Global Platinum Anti-tumor Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Platinum Anti-tumor Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Platinum Anti-tumor Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Platinum Anti-tumor Drugs Market Share by Region (2018-2024)
Table 10. Global Platinum Anti-tumor Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Platinum Anti-tumor Drugs Market Share by Region (2024-2029)
Table 12. Platinum Anti-tumor Drugs Market Trends
Table 13. Platinum Anti-tumor Drugs Market Drivers
Table 14. Platinum Anti-tumor Drugs Market Challenges
Table 15. Platinum Anti-tumor Drugs Market Restraints
Table 16. Global Platinum Anti-tumor Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Platinum Anti-tumor Drugs Revenue Share by Players (2018-2024)
Table 18. Global Top Platinum Anti-tumor Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum Anti-tumor Drugs as of 2022)
Table 19. Global Platinum Anti-tumor Drugs Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Platinum Anti-tumor Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Platinum Anti-tumor Drugs, Headquarters and Area Served
Table 22. Global Key Players of Platinum Anti-tumor Drugs, Product and Application
Table 23. Global Key Players of Platinum Anti-tumor Drugs, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Platinum Anti-tumor Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Platinum Anti-tumor Drugs Revenue Market Share by Type (2018-2024)
Table 27. Global Platinum Anti-tumor Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Platinum Anti-tumor Drugs Revenue Market Share by Type (2024-2029)
Table 29. Global Platinum Anti-tumor Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Platinum Anti-tumor Drugs Revenue Share by Application (2018-2024)
Table 31. Global Platinum Anti-tumor Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Platinum Anti-tumor Drugs Revenue Share by Application (2024-2029)
Table 33. North America Platinum Anti-tumor Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Platinum Anti-tumor Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Platinum Anti-tumor Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Platinum Anti-tumor Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Platinum Anti-tumor Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Platinum Anti-tumor Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Platinum Anti-tumor Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Platinum Anti-tumor Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Platinum Anti-tumor Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Platinum Anti-tumor Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Platinum Anti-tumor Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Platinum Anti-tumor Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Platinum Anti-tumor Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Platinum Anti-tumor Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Platinum Anti-tumor Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Platinum Anti-tumor Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Platinum Anti-tumor Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Platinum Anti-tumor Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Platinum Anti-tumor Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Platinum Anti-tumor Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Platinum Anti-tumor Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Platinum Anti-tumor Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Platinum Anti-tumor Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Platinum Anti-tumor Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Platinum Anti-tumor Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 65. Sanofi Company Details
Table 66. Sanofi Business Overview
Table 67. Sanofi Platinum Anti-tumor Drugs Product
Table 68. Sanofi Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 69. Sanofi Recent Developments
Table 70. Hengrui Medicine Company Details
Table 71. Hengrui Medicine Business Overview
Table 72. Hengrui Medicine Platinum Anti-tumor Drugs Product
Table 73. Hengrui Medicine Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 74. Hengrui Medicine Recent Developments
Table 75. ASK Pharma Company Details
Table 76. ASK Pharma Business Overview
Table 77. ASK Pharma Platinum Anti-tumor Drugs Product
Table 78. ASK Pharma Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 79. ASK Pharma Recent Developments
Table 80. Yi Bai Pharmaceutical Company Details
Table 81. Yi Bai Pharmaceutical Business Overview
Table 82. Yi Bai Pharmaceutical Platinum Anti-tumor Drugs Product
Table 83. Yi Bai Pharmaceutical Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 84. Yi Bai Pharmaceutical Recent Developments
Table 85. Qilu Pharmaceutical Company Details
Table 86. Qilu Pharmaceutical Business Overview
Table 87. Qilu Pharmaceutical Platinum Anti-tumor Drugs Product
Table 88. Qilu Pharmaceutical Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 89. Qilu Pharmaceutical Recent Developments
Table 90. Teva Company Details
Table 91. Teva Business Overview
Table 92. Teva Platinum Anti-tumor Drugs Product
Table 93. Teva Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 94. Teva Recent Developments
Table 95. Pfizer Company Details
Table 96. Pfizer Business Overview
Table 97. Pfizer Platinum Anti-tumor Drugs Product
Table 98. Pfizer Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 99. Pfizer Recent Developments
Table 100. Dr Reddy's Laboratories Company Details
Table 101. Dr Reddy's Laboratories Business Overview
Table 102. Dr Reddy's Laboratories Platinum Anti-tumor Drugs Product
Table 103. Dr Reddy's Laboratories Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 104. Dr Reddy's Laboratories Recent Developments
Table 105. Viatris Company Details
Table 106. Viatris Business Overview
Table 107. Viatris Platinum Anti-tumor Drugs Product
Table 108. Viatris Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 109. Viatris Recent Developments
Table 110. Sun Pharma Company Details
Table 111. Sun Pharma Business Overview
Table 112. Sun Pharma Platinum Anti-tumor Drugs Product
Table 113. Sun Pharma Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 114. Sun Pharma Recent Developments
Table 115. Novartis Company Details
Table 116. Novartis Business Overview
Table 117. Novartis Platinum Anti-tumor Drugs Product
Table 118. Novartis Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 119. Novartis Recent Developments
Table 120. Debiopharm Company Details
Table 121. Debiopharm Business Overview
Table 122. Debiopharm Platinum Anti-tumor Drugs Product
Table 123. Debiopharm Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 124. Debiopharm Recent Developments
Table 125. Accord Healthcare Company Details
Table 126. Accord Healthcare Business Overview
Table 127. Accord Healthcare Platinum Anti-tumor Drugs Product
Table 128. Accord Healthcare Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 129. Accord Healthcare Recent Developments
Table 130. SK Chemicals Company Details
Table 131. SK Chemicals Business Overview
Table 132. SK Chemicals Platinum Anti-tumor Drugs Product
Table 133. SK Chemicals Revenue in Platinum Anti-tumor Drugs Business (2018-2024) & (US$ Million)
Table 134. SK Chemicals Recent Developments
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Platinum Anti-tumor Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Platinum Anti-tumor Drugs Market Share by Type: 2022 VS 2029
Figure 3. Cisplatin Features
Figure 4. Oxaliplatin Features
Figure 5. Carboplatin Features
Figure 6. Other Features
Figure 7. Global Platinum Anti-tumor Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Platinum Anti-tumor Drugs Market Share by Application: 2022 VS 2029
Figure 9. Colorectal Cancer Case Studies
Figure 10. Ovarian Cancer Case Studies
Figure 11. Lung Cancer Case Studies
Figure 12. Other Case Studies
Figure 13. Platinum Anti-tumor Drugs Report Years Considered
Figure 14. Global Platinum Anti-tumor Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Platinum Anti-tumor Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Platinum Anti-tumor Drugs Market Share by Region: 2022 VS 2029
Figure 17. Global Platinum Anti-tumor Drugs Market Share by Players in 2022
Figure 18. Global Top Platinum Anti-tumor Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum Anti-tumor Drugs as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Platinum Anti-tumor Drugs Revenue in 2022
Figure 20. North America Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Platinum Anti-tumor Drugs Market Share by Type (2018-2029)
Figure 22. North America Platinum Anti-tumor Drugs Market Share by Application (2018-2029)
Figure 23. North America Platinum Anti-tumor Drugs Market Share by Country (2018-2029)
Figure 24. United States Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Platinum Anti-tumor Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Platinum Anti-tumor Drugs Market Share by Type (2018-2029)
Figure 28. Europe Platinum Anti-tumor Drugs Market Share by Application (2018-2029)
Figure 29. Europe Platinum Anti-tumor Drugs Market Share by Country (2018-2029)
Figure 30. Germany Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Platinum Anti-tumor Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Platinum Anti-tumor Drugs Market Share by Type (2018-2029)
Figure 38. China Platinum Anti-tumor Drugs Market Share by Application (2018-2029)
Figure 39. Asia Platinum Anti-tumor Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Platinum Anti-tumor Drugs Market Share by Type (2018-2029)
Figure 41. Asia Platinum Anti-tumor Drugs Market Share by Application (2018-2029)
Figure 42. Asia Platinum Anti-tumor Drugs Market Share by Region (2018-2029)
Figure 43. Japan Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Platinum Anti-tumor Drugs Market Share by Country (2018-2029)
Figure 53. Brazil Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Platinum Anti-tumor Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Sanofi Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 60. Hengrui Medicine Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 61. ASK Pharma Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 62. Yi Bai Pharmaceutical Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 63. Qilu Pharmaceutical Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 64. Teva Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 65. Pfizer Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 66. Dr Reddy's Laboratories Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 67. Viatris Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 68. Sun Pharma Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 69. Novartis Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 70. Debiopharm Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 71. Accord Healthcare Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 72. SK Chemicals Revenue Growth Rate in Platinum Anti-tumor Drugs Business (2018-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries